MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21
Cited by 21
Related Papers
Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis
|The Lancet|2014|3.2k
A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China
|The Lancet|2021|579
Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
|Cancer Research|2009|490